20/20 GeneSystems, Inc.

Our blood test for the early detection of lung cancer is positioned to generate over $75 million in revenue w/in 30 months of closing this financing round.

  • Stage $500K in TTM Revenue
  • Industry Biotechnology
  • Location Rockville, MD, US
  • Currency USD
  • Employees 12
  • Website 2020gene.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free